Who Paid My Doc
Lunsumio
Biological BioOncology
NDC 50242-159-01
General payments
$1,388,399
Research payments
$43,370,755
Through program year 2025, $1,388,399 in general payments and $43,370,755 in research payments were reported against Lunsumio (BioOncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $277,217 | 620 |
| 2025 | Research | $10,609,874 | 860 |
| 2024 | General | $342,562 | 3,631 |
| 2024 | Research | $16,270,472 | 3,301 |
| 2023 | General | $768,620 | 4,449 |
| 2023 | Research | $16,331,801 | 702 |
| 2022 | Research | $158,607 | 9 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
8,700 general · 4,872 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.